Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,843 | 62,637 | 67,233 | 71,944 | 26,470 |
| TOTAL | $57,564 | $63,844 | $67,659 | $72,453 | $27,208 |
| Non-Current Assets | |||||
| PPE Net | 2,584 | 2,314 | 2,165 | 1,895 | 864 |
| Intangibles | 2,952 | 1,300 | 1,252 | 1,149 | 987 |
| TOTAL | $5,536 | $3,614 | $3,417 | $3,044 | $1,850 |
| Total Assets | $63,100 | $67,459 | $71,076 | $75,497 | $29,059 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,176 | 771 | 480 | 453 | 582 |
| Accrued Expenses | 2,407 | 2,146 | 1,331 | 971 | 776 |
| TOTAL | $4,133 | $2,917 | $1,811 | $1,425 | $1,359 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 550 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,133 | $2,917 | $1,811 | $1,425 | $1,359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,767 | 18,781 | 18,641 | 18,686 | N/A |
| Common Shares | 188 | 188 | 187 | 186 | 28 |
| Retained earnings | -46,584 | -39,939 | -34,210 | -28,499 | -23,099 |
| Other shareholders' equity | -5,134 | -5,978 | -7,679 | -8,686 | -9,511 |
| TOTAL | $58,967 | $64,541 | $69,265 | $74,072 | $27,700 |
| Total Liabilities And Equity | $63,100 | $67,459 | $71,076 | $75,497 | $29,059 |